Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3666PDF: 3021HTML: 181 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1933PDF: 604HTML: 234 -
The diagnostic pitfalls of mucormycosis
814PDF: 687HTML: 223 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1094PDF: 996HTML: 171 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1512PDF: 772HTML: 136 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1232PDF: 1048PDF: 840HTML: 143 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12218PDF: 1623HTML: 4138Cover letter: 176Figure 1: 171 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3967PDF: 1100HTML: 1913Fig.1: 202Fig. 2: 101Table 1: 183Table2: 198Table 3: 178 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
792PDF: 477HTML: 1282 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1680PDF: 639HTML: 309 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2388PDF: 753HTML: 1718 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
943PDF: 1067Suppl. Files: 548HTML: 71 -
Anemia in the elderly: not always what it seems.
3222PDF: 984HTML: 1749Figure 1: 156Figure 1 revised: 159 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2475PDF: 1082HTML: 120 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1664PDF: 918HTML: 126 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4684PDF: 1702HTML: 2685Untitled: 188 -
Common parasite with uncommon associations
1457PDF: 644HTML: 1823 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4283PDF: 864HTML: 1296Table1: 164 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1898PDF: 682HTML: 668Table1: patient's characteristics: 136Table 2: profile of each patient: 161 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1298PDF: 1264HTML: 77 -
Osteolytic bone lesions – A rare presentation of AML M6.
1919PDF: 1050HTML: 7898Untitled: 181 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1469PDF: 555HTML: 167 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1293PDF: 850HTML: 1751 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1340PDF: 893HTML: 1636Figure 1: 157







